... Finally, I had the opportunity to tour iBio, a local business that uses a proprietary system to quickly produce protein vaccines and biotherapeutic candidates for unmet medical needs. iBio is on the front line combatting the COVID-19 pandemic and working to develop a plant-based vaccine that can help key vulnerable populations that may require alternative options to other vaccine types. They have the capacity to produce about 500 million doses of vaccine annually – capabilities that will be critically important as we start efforts to vaccinate hardworking American families to stop COVID-19.”..
flores.house.gov/news/documentsingle.aspx?DocumentID=401346